Epizyme (EPZM) Reports Q3 Loss, Misses Revenue Estimates

Published on November 9, 2021

Epizyme (EPZM) delivered earnings and revenue surprises of -42.22% and -40.23%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?